As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease. At Memorial Sloan Kettering Cancer Center (MSK), neurosurgeon Nelson Moss, ...

Since she enrolled in a clinical trial at MSK to treat her low-grade serous ovarian cancer, Ellen Coopersmith has a new outlook on life. The first drug for a rare and difficult-to-treat type of ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Tell us what you think Your feedback will help us improve the educational information we provide. Your care team cannot see anything you write on this feedback form. Please do not use it to ask about ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

In 2019, Michael Rosenblum received an experimental new prostate cancer treatment after the disease spread to his bones. He remains symptom-free. The treatment is now approved for more patients.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Being trained as a chemical biologist, I am highly motivated to mentor the next generation of chemical biologists interested in developing tools and addressing important biological questions in the ...

How we will keep you safe while taking opioids At MSK, we talk with everyone about their drug and alcohol use at the start of their treatment with us. This helps us understand if you’re at risk for ...